VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andreas Samson who wrote (18318)	1/29/1999 12:35:00 AM
From: VLAD	Read Replies (1) of 23519

Andreas, Just out of curiosity.....are you in any way impressed by the fact that 3 months after the launch of Viagra, MUSE was able to capture 34% of the ED market in England and 37% of the ED market in Sweden? Did you know that in Sweden the national health care system covers Viagra yet MUSE was still able to rebound to 37% of the ED script count for ED products? Everyone was earlier claiming that they would be happy if MUSE could capture only a mere 5 to 10% of the ED market. Well, it looks to me that conservatively speaking, MUSE if marketed properly may be able to command at least 20 to 25% of the market. I think the most frustrating thing here is that we have a pretty decent product in a rapidly growing market but no marketing arm right here in the land of milk and honey. Another good question for Vivus would have been to ask them exactly what they are currently doing to market MUSE in a cost efficient manner. I never even got a thank you for your input reply from Vivus after we all compiled a list of internet sights which could give MUSE cheap exposure to PCPs and the target group of older folks: www3.techstocks.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next